Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (1511-1520 of 1,873) with videos related to

Pageof 188
Sort By:
European Journal of Heart Failure|May 22, 2023
Electronic nudges to increase influenza vaccination uptake among patients with heart failure: A pre-specified analysis of the NUDGE-FLU trialNiklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.
JACC. Heart Failure|December 9, 2025
Finerenone-Related Risk of Hypotension in Heart Failure With Mildly Reduced or Preserved Ejection FractionAlberto Foà, Muthiah Vaduganathan, Brian L Claggett, et al.
Journal of the American College of Cardiology|May 14, 2021
Kidney Function and Outcomes in Patients Hospitalized With Heart FailureRavi B Patel, Gregg C Fonarow, Stephen J Greene, et al.
JAMA Cardiology|October 13, 2021
Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical TrialG Michael Felker, Scott D Solomon, Brian Claggett, et al.
European Heart Journal|January 12, 2023
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fractionJames P Curtain, Carly Adamson, Toru Kondo, et al.
European Journal of Heart Failure|March 2, 2026
Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trialYasuhiro Hamatani, Brian L Claggett, Ian J Kulac, et al.
JAMA Cardiology|November 17, 2024
Kidney Outcomes in Transthyretin Amyloid CardiomyopathyAdam Ioannou, Yousuf Razvi, Aldostefano Porcari, et al.
Circulation. Heart Failure|November 16, 2024
Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical TrialsPablo M Marti-Castellote, Christopher Reeder, Brian Claggett, et al.
Respiratory Investigation|November 2, 2025
Effects of high-dose versus standard-dose influenza vaccine among patients with chronic lung disease: A prespecified analysis of the DANFLU-1 trialLisa Steen Duus, Niklas Dyrby Johansen, Daniel Modin, et al.
European Journal of Heart Failure|July 5, 2019
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fractionLi Shen, Rasmus Rørth, Deborah Cosmi, et al.
Pageof 188

Showing results (1511-1520 of 1,873) with videos related to

Sort By:
Pageof 188
European Journal of Heart Failure|May 22, 2023
Electronic nudges to increase influenza vaccination uptake among patients with heart failure: A pre-specified analysis of the NUDGE-FLU trialNiklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.
JACC. Heart Failure|December 9, 2025
Finerenone-Related Risk of Hypotension in Heart Failure With Mildly Reduced or Preserved Ejection FractionAlberto Foà, Muthiah Vaduganathan, Brian L Claggett, et al.
Journal of the American College of Cardiology|May 14, 2021
Kidney Function and Outcomes in Patients Hospitalized With Heart FailureRavi B Patel, Gregg C Fonarow, Stephen J Greene, et al.
JAMA Cardiology|October 13, 2021
Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical TrialG Michael Felker, Scott D Solomon, Brian Claggett, et al.
European Heart Journal|January 12, 2023
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fractionJames P Curtain, Carly Adamson, Toru Kondo, et al.
European Journal of Heart Failure|March 2, 2026
Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trialYasuhiro Hamatani, Brian L Claggett, Ian J Kulac, et al.
JAMA Cardiology|November 17, 2024
Kidney Outcomes in Transthyretin Amyloid CardiomyopathyAdam Ioannou, Yousuf Razvi, Aldostefano Porcari, et al.
Circulation. Heart Failure|November 16, 2024
Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical TrialsPablo M Marti-Castellote, Christopher Reeder, Brian Claggett, et al.
Respiratory Investigation|November 2, 2025
Effects of high-dose versus standard-dose influenza vaccine among patients with chronic lung disease: A prespecified analysis of the DANFLU-1 trialLisa Steen Duus, Niklas Dyrby Johansen, Daniel Modin, et al.
European Journal of Heart Failure|July 5, 2019
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fractionLi Shen, Rasmus Rørth, Deborah Cosmi, et al.
Pageof 188